Canada Markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.18-1.87 (-6.91%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close27.05
Open27.34
Bid25.20 x 900
Ask25.79 x 800
Day's Range24.50 - 27.34
52 Week Range15.19 - 53.69
Volume2,029,854
Avg. Volume1,873,057
Market Cap5.349B
Beta (5Y Monthly)1.06
PE Ratio (TTM)N/A
EPS (TTM)-0.34
Earnings DateFeb. 08, 2022 - Feb. 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est47.00
  • Zacks

    PacBio's (PACB) Collaboration to Boost Rare Disease Diagnosis

    PacBio's (PACB) recent partnership with ARUP Laboratories, with regard to a study, has the potential to enhance rare disease diagnosis.

  • GlobeNewswire

    Organogenesis Appoints Prathyusha Duraibabu to Board of Directors

    CANTON, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced the appointment of Prathyusha Duraibabu to the Company’s Board of Directors, effective November 19, 2021. Ms. Duraibabu will serve as an independent director of the Company and member of the Audit Co

  • GlobeNewswire

    PacBio Grants Equity Incentive Award to New Employee

    MENLO PARK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares of PacBio common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity I